RAB0195

Human VEGF R3 ELISA Kit

Name: Human VEGF R3 ELISA Kit
Brand: SIGMA
Price: 2330 PLN

for serum, plasma, cell culture supernatant, urine

Slide 1 of 2

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

1 KIT

2330,00 zł

Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności

Informacje o tej pozycji

NACRES:

NA.32

UNSPSC Code:

41116158

Gene information:

human ... FLT4(2324)

Input:

sample type serum
sample type cell culture supernatant(s)
sample type plasma
sample type urine

Species reactivity:

human

Storage temp.:

−20°C

Shipped in:

wet ice

Kluczowe dokumenty

Wyświetl całą dokumentację

Przejdź do

Pomoc techniczna

Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.

Pozwól nam pomóc

species reactivity

human

packaging

kit of 96 wells (12 strips x 8 wells)

technique(s)

ELISA: suitable, capture ELISA: suitable

input

sample type serum
sample type cell culture supernatant(s)
sample type plasma
sample type urine

assay range

inter-assay cv: <12%
intra-assay cv: <10%
sensitivity: 15 pg/mL
standard curve range: 12.29-3000 pg/mL

detection method

colorimetric

shipped in

wet ice

storage temp.

−20°C

Gene Information

human ... FLT4(2324)

Powiązane kategorie

Enzyme-Linked Immunosorbent Assay (ELISA) Kits

Immunoassay Platform Solutions

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 4

Ta pozycja	RAB0328	RAB0513	RAB0410
Sigma-Aldrich RAB0195 Human VEGF R3 ELISA Kit	Sigma-Aldrich RAB0328 Human VEGF R2 ELISA Kit	Sigma-Aldrich RAB0513 Human VEGF-C ELISA Kit	Sigma-Aldrich RAB0410 Human EG-VEGF / PK1 ELISA Kit
species reactivity human	species reactivity human	species reactivity human	species reactivity human
Gene Information human ... FLT4(2324)	Gene Information human ... KDR(3791)	Gene Information human ... VEGFC(7424)	Gene Information human ... PROK1(84432)
input sample type serum sample type cell culture supernatant(s) sample type plasma sample type urine	input sample type plasma sample type serum sample type cell culture supernatant(s) sample type urine	input sample type cell culture supernatant(s) sample type serum sample type urine sample type plasma	input sample type cell culture supernatant(s) sample type plasma sample type urine sample type serum
assay range inter-assay cv: <12% intra-assay cv: <10% sensitivity: 15 pg/mL standard curve range: 12.29-3000 pg/mL	assay range inter-assay cv: <12% intra-assay cv: <10% sensitivity: 70 pg/mL standard curve range: 34.3-25000 pg/mL	assay range inter-assay cv: <12% intra-assay cv: <10% sensitivity: 15 pg/mL standard curve range: 13.72-10000 pg/mL	assay range inter-assay cv: <12% intra-assay cv: <10% sensitivity: 10 pg/mL standard curve range: 13.72-10000 pg/mL
technique(s) ELISA: suitable, capture ELISA: suitable	technique(s) ELISA: suitable, capture ELISA: suitable	technique(s) ELISA: suitable, capture ELISA: suitable	technique(s) ELISA: suitable, capture ELISA: suitable
packaging kit of 96 wells (12 strips x 8 wells)	packaging kit of 96 wells (12 strips x 8 wells)	packaging kit of 96 wells (12 strips x 8 wells)	packaging kit of 96 wells (12 strips x 8 wells)

General description

The Human VEGF R3 (Vascular Endothelial Growth Factor Receptor 3) ELISA (Enzyme-Linked Immunosorbent Assay) kit is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of human VEGF R3 in serum, plasma, cell culture supernatants and urine.

Immunogen

Recombinant Human VEGFR3

Application

For research use only. Not for use in diagnostic procedures.
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)

Other Notes

A sample Certificate of Analysis is available for this product.
Please type the word sample in the text box provided for lot number.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Elementy zestawu są też dostępne oddzielnie

Numer produktu

Opis

Karta charakterystyki

RABELADAELISA 1X Assay/Sample Diluent Buffer A (Item D1)Karta charakterystyki

RABELADBELISA 5X Assay/Sample Diluent Buffer B (Item E1)Karta charakterystyki

RABSTOP3ELISA Stop Solution (Item I)Karta charakterystyki

RABTMB3ELISA Colorimetric TMB Reagent (HRP Substrate, Item H)Karta charakterystyki

RABWASH420X Wash Buffer (Item B)Karta charakterystyki

pictograms

GHS05

signalword

Warning

hcodes

H290

pcodes

P234 - P390

Hazard Classifications

Met. Corr. 1

Klasa składowania

10 - Combustible liquids

Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

SAMPLE

0825B0281

Nie widzisz odpowiedniej wersji?

Jeśli potrzebujesz konkretnej wersji, możesz wyszukać konkretny certyfikat według numeru partii lub serii.

Wyszukaj dokument COA

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.

Fumitaka Shimizu et al.

PloS one, 9(3), e92872-e92872 (2014-04-02)

Pathological destruction of blood-brain barrier (BBB) has been thought to be the initial key event in the process of developing multiple sclerosis (MS). The purpose of the present study was to clarify the possible molecular mechanisms responsible for the malfunction

Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis.

Guodong Zhang et al.

Proceedings of the National Academy of Sciences of the United States of America, 111(30), 11127-11132 (2014-07-16)

Prostaglandins derived from the cyclooxygenase (COX) pathway and epoxyeicosatrienoic acids (EETs) from the cytochrome P450/soluble epoxide hydrolase (sEH) pathway are important eicosanoids that regulate angiogenesis and tumorigenesis. COX-2 inhibitors, which block the formation of prostaglandins, suppress tumor growth, whereas sEH

Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway.

Teng Jiang et al.

British journal of pharmacology, 171(18), 4222-4232 (2014-05-16)

As a newer component of the renin-angiotensin system, angiotensin-(1-7) [Ang-(1-7) ] has been shown to facilitate angiogenesis and protect against ischaemic damage in peripheral tissues. However, the role of Ang-(1-7) in brain angiogenesis remains unclear. The aim of this study was

Comparison of the efficacy of aflibercept, ranibizumab, and bevacizumab in an RPE/choroid organ culture.

Alexa Klettner et al.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 252(10), 1593-1598 (2014-07-23)

Anti-VEGF treatment is the therapy of choice in age-related macular degeneration and is also applied in diabetic macular edema or retinal vein occlusion. Recently, aflibercept has been approved for therapeutic use. In this study, we investigate the efficacy of aflibercept

Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.

Raimo Tuuminen et al.

Acta ophthalmologica, 92(7), 675-681 (2014-02-11)

To investigate the intravitreal levels of potent vasoactive, angiogenic and extracellular matrix remodelling factors in the diabetic patients with simvastatin treatment. This is an institutional, prospective, observational case-control study. Type-1 and type-2 diabetic patients on lipophilic simvastatin (N = 14)

Wyświetl wszystkie powiązane dokumenty

Powiązane treści

ELISA Kit Information

Instructions

User Guide-RAB0195

Questions

Reviews

No rating value

Active Filters

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej